MAB8257F
Anti-Influenza A Antibody, nucleoprotein, clone A1, FITC-conjugated
clone A1, Chemicon®, from mouse
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
FITC conjugate
Clone:
A1, monoclonal
Application:
IF
Citations:
10
biological source
mouse
conjugate
FITC conjugate
antibody form
purified antibody
antibody product type
primary antibodies
clone
A1, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG2a
shipped in
wet ice
Quality Level
Immunogen
Epitope: nucleoprotein
Influenza A
Application
Indirect Immunofluorescence
Optimal dilutions must be determined by end user.
Optimal dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Influenza A Antibody, nucleoprotein, clone A1, FITC-conjugated is validated for use in IF for the detection of Influenza A.
Biochem/physiol Actions
Specific for the Influenza A nucleoprotein. Has stronger binding with N1-type Flu A. No cross reactivity seen to influenza B or other respiratory viruses.
Physical form
Purified, FITC conjugated. Liquid in 0.02M phosphate buffer, 0.25M sodium chloride, pH 7.6 with 15 mg/mL BSA and 0.1% sodium azide
Preparation Note
Store at 2° to 8°C.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Katherine S Xue et al.
eLife, 5, e13974-e13974 (2016-03-16)
RNA viruses rapidly diversify into quasispecies of related genotypes. This genetic diversity has long been known to facilitate adaptation, but recent studies have suggested that cooperation between variants might also increase population fitness. Here, we demonstrate strong cooperation between two
Cheng-Chung Lee et al.
Scientific reports, 9(1), 4546-4546 (2019-03-16)
Influenza is a contagious acute respiratory disease caused by the influenza virus infection. Hemagglutinin (HA) is an important target in the therapeutic treatment and diagnostic detection of the influenza virus. Influenza A virus encompasses several different HA subtypes with different
David F Boyd et al.
Nature, 587(7834), 466-471 (2020-10-30)
Severe respiratory infections can result in acute respiratory distress syndrome (ARDS)1. There are no effective pharmacological therapies that have been shown to improve outcomes for patients with ARDS. Although the host inflammatory response limits spread of and eventually clears the
Jenna M Kastenschmidt et al.
Immunity, 56(8), 1910-1926 (2023-07-22)
Highly effective vaccines elicit specific, robust, and durable adaptive immune responses. To advance informed vaccine design, it is critical that we understand the cellular dynamics underlying responses to different antigen formats. Here, we sought to understand how antigen-specific B and
Kamonthip Rungrojcharoenkit et al.
PloS one, 15(8), e0237218-e0237218 (2020-08-08)
Influenza is an infectious respiratory illness caused by influenza viruses. Despite yearly updates, the efficacy of influenza vaccines is significantly curtailed by the virus antigenic drift and antigenic shift. These constant changes to the influenza virus make-up also challenge the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持